QR-Code

P55 | MANAGEMENT OF NEUROLOGICAL TOXICITIES OF PATIENTS TREATED WITH IMMUNOTHERAPIES FOR MULTIPLE MYELOMA: A SINGLE-CENTER REAL WORLD EXPERIENCE

T cell redirecting therapies (TCRt) have dramatically improved the prognosis of relapsed/refractory multiple myeloma (RRMM) patients (pts), but they are also burdened by novel toxicities, among which neurological ones such as immune cell associated neurotoxicity syndrome (ICANS), headache, and neur...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: E. Manzato, M. Puppi, M. Talarico, M. Iezza, S. Masci, S. Ghibellini, A. Vitale, S. Barbato, P. Tacchetti, L. Pantani, K. Mancuso, E. Zamagni
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ferrata Storti Foundation 2026-04-01
Schriftenreihe:Haematologica
Online-Zugang:https://haematologica.org/article/view/14068
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!